Patients with Morquio A aged 5years ( N = 176 ) were randomised ( 1:1:1 ) to receive elosulfase alfa 2.0 mg/kg/every other week ( qow ) , elosulfase alfa 2.0 mg/kg/week ( weekly ) or placebo for 24weeks in this phase 3 , double-blind , randomised study .